Janney Montgomery Scott
DFTX

Janney Montgomery Scott’s Definium Therapeutics DFTX Stock Holding History

Janney Montgomery Scott’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
+26,664
New +$659K ﹤0.01% 1777
2025
Q2 		– Sell
-34,685
Closed -$203K – 2786
2025
Q1 		$203K Buy
+34,685
New +$248K ﹤0.01% 2529

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Janney Montgomery Scott's DFTX Position: Q2 2026 in Review

Janney Montgomery Scott opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 26,664 shares worth $1.25M. The stake represents ﹤0.01% of the portfolio and ranks #1777 among its holdings. This is a return to the name: Janney Montgomery Scott previously reported a position in DFTX as recently as Q1 2025.

Janney Montgomery Scott first reported a position in DFTX in Q1 2025 and has held it in 2 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Janney Montgomery Scott held 26,664 shares of Definium Therapeutics worth $1.25M as of Q2 2026.
  • Definium Therapeutics was a new Janney Montgomery Scott position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #1777 holding.
  • Janney Montgomery Scott first reported a position in Definium Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.